Fenton, MO, United States of America

Dennis J Kalota

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 2.3

ph-index = 9

Forward Citations = 212(Granted Patents)


Company Filing History:


Years Active: 1989-2012

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Dennis J Kalota - Innovator in Opiate Production Processes

Introduction

Dennis J Kalota is a notable inventor based in Fenton, MO (US) with an impressive portfolio of 25 patents. His contributions to the field of chemical engineering and pharmaceuticals, particularly in the production of opiate alkaloids, have significantly advanced the industry.

Latest Patents

Among his latest innovations are two key patents:

1. **Processes for the Production of Buprenorphine with Reduced Impurity Formation** - This invention focuses on a method for producing buprenorphine or its derivatives while minimizing the creation of impurities.

2. **Recycling Process for Increasing the Yield of Opiate Alkaloid Derivatives** - This patent outlines a technique designed to enhance the yield of opiate alkaloids by implementing multiple recycling steps in the production process.

Career Highlights

Throughout his career, Dennis J Kalota has made substantial contributions while working at prominent companies such as Monsanto Company and Solutia Incorporated. His innovative spirit and technical expertise have positioned him as a leading figure in his field.

Collaborations

Dennis has collaborated with several accomplished professionals, including David C Silverman and John S McConaghy, Jr. These partnerships have fostered creativity and innovation, leading to advancements in the production of crucial pharmaceutical compounds.

Conclusion

Dennis J Kalota is a distinguished inventor whose work has significantly influenced the pharmaceutical industry. His commitment to innovation, combined with his technical prowess, ensures that he remains a key player in the development of new processes for opiate alkaloid production. As the landscape of pharmaceuticals evolves, his contributions will continue to be relevant and impactful.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…